Rallybio (RLYB) Cash from Investing Activities (2020 - 2026)

Rallybio has reported Cash from Investing Activities for 7 years, with the latest figure at $17.9 million in Q1 2026.

• Quarterly Cash from Investing Activities rose 61.54% year-over-year to $17.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $54.1 million (up 57.65% YoY) and the FY2025 annual result came in at $47.3 million, up 41.13% from the prior year.
• Cash from Investing Activities rose to $17.9 million in Q1 2026 per RLYB's latest filing, from $3.9 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $29.2 million in Q3 2025 and troughed at -$80.2 million in Q1 2022.
• A 5-year average of $832235.3 and a median of $3.9 million in 2025 frame the typical range for Cash from Investing Activities.
• The widest YoY moves for Cash from Investing Activities: up 4540.0% in 2022, down 22269.34% in 2022.
• Over 5 years, Cash from Investing Activities stood at -$30.6 million in 2022, then surged by 155.18% to $16.9 million in 2023, then plunged by 109.3% to -$1.6 million in 2024, then soared by 349.52% to $3.9 million in 2025, then surged by 356.05% to $17.9 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered $17.9 million, $3.9 million, and $29.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.